关注
Frederik Thomsen
Frederik Thomsen
Department of Urology, Copenhagen University Hospital, Herlev and Gentofte Hospital
在 regionh.dk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Active surveillance for clinically localized prostate cancer––A systematic review
FB Thomsen, K Brasso, LH Klotz, MA Røder, KD Berg, P Iversen
Journal of surgical oncology 109 (8), 830-835, 2014
2482014
Enzalutamide antitumour activity against metastatic castration-resistant prostate cancer previously treated with docetaxel and abiraterone: a multicentre analysis
K Brasso, FB Thomsen, AJ Schrader, SC Schmid, D Lorente, M Retz, ...
European urology 68 (2), 317-324, 2015
1342015
ERG protein expression in diagnostic specimens is associated with increased risk of progression during active surveillance for prostate cancer
KD Berg, B Vainer, FB Thomsen, MA Røder, TA Gerds, BG Toft, K Brasso, ...
European urology 66 (5), 851-860, 2014
1062014
Enzalutamide treatment in patients with metastatic castration-resistant prostate cancer progressing after chemotherapy and abiraterone acetate
FB Thomsen, MA Røder, P Rathenborg, K Brasso, M Borre, P Iversen
Scandinavian journal of urology 48 (3), 268-275, 2014
732014
Pulmonary function in patients with germ cell cancer treated with bleomycin, etoposide, and cisplatin
J Lauritsen, MGG Kier, M Bandak, MS Mortensen, FB Thomsen, ...
Journal Of Clinical Oncology 34 (13), 1492-1499, 2016
692016
Active surveillance can reduce overtreatment in patients with low-risk prostate cancer
FB Thomsen, MA Røder, H Hvarness, P Iversen, K Brasso
Dan Med J 60 (2), A4575, 2013
642013
Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study
FB Thomsen, M Westerberg, H Garmo, D Robinson, L Holmberg, ...
PLoS One 15 (1), e0228447, 2020
402020
Improved survival for patients with de novo metastatic prostate cancer in the last 20 years
KD Berg, FB Thomsen, MK Mikkelsen, IJ Ingimarsdóttir, RB Hansen, ...
European Journal of Cancer 72, 20-27, 2017
392017
The risk of biochemical recurrence for intermediate-risk prostate cancer after radical prostatectomy
S Kurbegovic, KD Berg, FB Thomsen, L Gruschy, P Iversen, K Brasso, ...
Scandinavian journal of urology 51 (6), 450-456, 2017
342017
Active surveillance for localized prostate cancer: nationwide observational study
FB Thomsen, H Jakobsen, NC Langkilde, M Borre, EB Jakobsen, A Frey, ...
The Journal of urology 201 (3), 520-527, 2019
322019
Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: long-term follow-up of the SPCG-6 study
FB Thomsen, K Brasso, IJ Christensen, JE Johansson, A Angelsen, ...
European journal of cancer 51 (10), 1283-1292, 2015
312015
Association of radical local treatment with mortality in men with very high-risk prostate cancer: a semiecologic, nationwide, population-based study
P Stattin, F Sandin, FB Thomsen, H Garmo, D Robinson, IF Lissbrant, ...
European Urology 72 (1), 125-134, 2017
302017
A predictive model based on biparametric magnetic resonance imaging and clinical parameters for improved risk assessment and selection of biopsy-naïve men for prostate biopsies
L Boesen, FB Thomsen, N Nørgaard, V Løgager, I Balslev, R Bisbjerg, ...
Prostate Cancer and Prostatic Diseases 22 (4), 609-616, 2019
292019
Gonadotropin-releasing hormone agonists, orchiectomy, and risk of cardiovascular disease: semi-ecologic, nationwide, population-based study
FB Thomsen, F Sandin, H Garmo, IF Lissbrant, G Ahlgren, ...
European urology 72 (6), 920-928, 2017
292017
The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading–a matched‐pair analysis
KD Berg, FB Thomsen, C Nerstrøm, MA Røder, P Iversen, BG Toft, ...
BJU international 117 (6), 883-889, 2016
252016
Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the placebo arm of the SPCG-6 study
FB Thomsen, K Brasso, KD Berg, TA Gerds, JE Johansson, A Angelsen, ...
Annals of Oncology 27 (3), 460-466, 2016
242016
Survival and toxicity in patients with disseminated germ cell cancer aged 40 years and older
FB Thomsen, M Bandak, MF Thomsen, J Lauritsen, IJ Christensen, ...
Cancer 120 (1), 43-51, 2014
232014
Active surveillance for localized prostate cancer: an analysis of patient contacts and utilization of healthcare resources
FB Thomsen, KD Berg, MA Røder, P Iversen, K Brasso
Scandinavian Journal of Urology 49 (1), 43-50, 2015
182015
Risk of malignant melanoma in men with prostate cancer: nationwide, population‐based cohort study
FB Thomsen, Y Folkvaljon, H Garmo, D Robinson, S Loeb, C Ingvar, ...
International Journal of Cancer 138 (9), 2154-2160, 2016
172016
Prostate‐specific antigen doubling time as a progression criterion in an active surveillance programme for patients with localized prostate cancer
FB Thomsen, IJ Christensen, K Brasso, MA Røder, P Iversen
BJU international 113 (5b), E98-E105, 2014
172014
系统目前无法执行此操作,请稍后再试。
文章 1–20